Although this medication was used to treat RCC in the past, due to low levels of effectiveness and poor tolerance, it has largely replaced by molecularly targeted therapies and other immunotherapies, such as immune-checkpoint inhibitors.
If this has been prescribed to treat your RCC, it is recommended to consult with another physician for a second opinion to ensure you are being offered the most effective treatment for your medical situation.
Please contact the KCA Patient Navigator with any additional questions.
Revised May 2022